Copyright Reports & Markets. All rights reserved.

Global Noninvasive Cancer Diagnostics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Noninvasive Cancer Diagnostics Industry
  • 1.7 COVID-19 Impact: Noninvasive Cancer Diagnostics Market Trends

    • 2 Global Noninvasive Cancer Diagnostics Quarterly Market Size Analysis

    • 2.1 Noninvasive Cancer Diagnostics Business Impact Assessment - COVID-19
      • 2.1.1 Global Noninvasive Cancer Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Noninvasive Cancer Diagnostics Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Noninvasive Cancer Diagnostics Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Noninvasive Cancer Diagnostics Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Noninvasive Cancer Diagnostics Market
    • 3.4 Key Players Noninvasive Cancer Diagnostics Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Noninvasive Cancer Diagnostics Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Clinical Chemistry
      • 1.4.2 Immunochemistry/Immunoassay
      • 1.4.3 Molecular Diagnostics
      • 1.4.4 Others
    • 4.2 By Type, Global Noninvasive Cancer Diagnostics Market Size, 2019-2021

    5 Impact of Covid-19 on Noninvasive Cancer Diagnostics Segments, By Application

    • 5.1 Overview
      • 5.5.1 Solid Tumors
      • 5.5.2 Blood Cancer
      • 5.5.3 Lung Cancer
      • 5.5.4 Breast Cancer
      • 5.5.5 Others
    • 5.2 By Application, Global Noninvasive Cancer Diagnostics Market Size, 2019-2021
      • 5.2.1 By Application, Global Noninvasive Cancer Diagnostics Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Precision Therapeutics, Inc. (U.S.)
      • 7.1.1 Precision Therapeutics, Inc. (U.S.) Business Overview
      • 7.1.2 Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Quarterly Revenue, 2020
      • 7.1.3 Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Product Introduction
      • 7.1.4 Precision Therapeutics, Inc. (U.S.) Response to COVID-19 and Related Developments
    • 7.2 A&G Pharmaceutical, Inc. (U.S.)
      • 7.2.1 A&G Pharmaceutical, Inc. (U.S.) Business Overview
      • 7.2.2 A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Quarterly Revenue, 2020
      • 7.2.3 A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Product Introduction
      • 7.2.4 A&G Pharmaceutical, Inc. (U.S.) Response to COVID-19 and Related Developments
    • 7.3 Affymetrix Inc. (U.S.)
      • 7.3.1 Affymetrix Inc. (U.S.) Business Overview
      • 7.3.2 Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Quarterly Revenue, 2020
      • 7.3.3 Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Product Introduction
      • 7.3.4 Affymetrix Inc. (U.S.) Response to COVID-19 and Related Developments
    • 7.4 AVIVA Biosciences Corporation (U.S.)
      • 7.4.1 AVIVA Biosciences Corporation (U.S.) Business Overview
      • 7.4.2 AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Quarterly Revenue, 2020
      • 7.4.3 AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Product Introduction
      • 7.4.4 AVIVA Biosciences Corporation (U.S.) Response to COVID-19 and Related Developments
    • 7.5 BIOVIEW Inc. (U.S.)
      • 7.5.1 BIOVIEW Inc. (U.S.) Business Overview
      • 7.5.2 BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Quarterly Revenue, 2020
      • 7.5.3 BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Product Introduction
      • 7.5.4 BIOVIEW Inc. (U.S.) Response to COVID-19 and Related Developments
    • 7.6 Laboratory Corporation of America Holdings (LabCorp) (U.S.)
      • 7.6.1 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Business Overview
      • 7.6.2 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Quarterly Revenue, 2020
      • 7.6.3 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Product Introduction
      • 7.6.4 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Response to COVID-19 and Related Developments
    • 7.7 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.)
      • 7.7.1 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Business Overview
      • 7.7.2 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Quarterly Revenue, 2020
      • 7.7.3 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Product Introduction
      • 7.7.4 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Response to COVID-19 and Related Developments
    • 7.8 Digene Corporation (U.S.)
      • 7.8.1 Digene Corporation (U.S.) Business Overview
      • 7.8.2 Digene Corporation (U.S.) Noninvasive Cancer Diagnostics Quarterly Revenue, 2020
      • 7.8.3 Digene Corporation (U.S.) Noninvasive Cancer Diagnostics Product Introduction
      • 7.8.4 Digene Corporation (U.S.) Response to COVID-19 and Related Developments
    • 7.9 Gen-Probe Incorporated (U.S.)
      • 7.9.1 Gen-Probe Incorporated (U.S.) Business Overview
      • 7.9.2 Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Quarterly Revenue, 2020
      • 7.9.3 Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Product Introduction
      • 7.9.4 Gen-Probe Incorporated (U.S.) Response to COVID-19 and Related Developments
    • 7.10 IVDiagnostics, Inc. (U.S.)
      • 7.10.1 IVDiagnostics, Inc. (U.S.) Business Overview
      • 7.10.2 IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Quarterly Revenue, 2020
      • 7.10.3 IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Product Introduction
      • 7.10.4 IVDiagnostics, Inc. (U.S.) Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Noninvasive Cancer Diagnostics, including the following market information:
      Global Noninvasive Cancer Diagnostics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Noninvasive Cancer Diagnostics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Noninvasive Cancer Diagnostics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Noninvasive Cancer Diagnostics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Precision Therapeutics, Inc. (U.S.), A&G Pharmaceutical, Inc. (U.S.), Affymetrix Inc. (U.S.), AVIVA Biosciences Corporation (U.S.), BIOVIEW Inc. (U.S.), Laboratory Corporation of America Holdings (LabCorp) (U.S.), Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.), Digene Corporation (U.S.), Gen-Probe Incorporated (U.S.), IVDiagnostics, Inc. (U.S.), etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Clinical Chemistry
      Immunochemistry/Immunoassay
      Molecular Diagnostics
      Others

      Based on the Application:
      Solid Tumors
      Blood Cancer
      Lung Cancer
      Breast Cancer
      Others

      Buy now